4//SEC Filing
BIODELIVERY SCIENCES INTERNATIONAL INC 4
Accession 0001209191-15-019819
CIK 0001103021operating
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 6:02 PM ET
Size
16.5 KB
Accession
0001209191-15-019819
Insider Transaction Report
Form 4
Finn Andrew L
Executive Vice President
Transactions
- Exercise/Conversion
Common Stock
2015-02-20+53,534→ 624,598 total - Exercise/Conversion
Common Stock
2015-02-22+51,529→ 676,127 total - Sale
Common Stock
2015-02-24$14.63/sh−52,330$765,588→ 623,797 total - Exercise/Conversion
Restricted Stock Units
2015-02-20−53,534→ 53,533 totalExercise: $0.00From: 2015-02-20Exp: 2016-02-20→ Common Stock (53,534 underlying) - Exercise/Conversion
Restricted Stock Units
2015-02-22−51,529→ 101,858 totalExercise: $0.00From: 2015-02-22Exp: 2017-02-22→ Common Stock (51,529 underlying) - Award
Restricted Stock Units
2015-02-23+400,000→ 400,000 totalExercise: $0.00Exp: 2018-02-23→ Common Stock (400,000 underlying)
Footnotes (5)
- [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of 53,534 Restricted Stock Units ("RSUs") granted to the Reporting Person on February 20, 2013 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs under this grant will vest on February 20, 2016.
- [F2]The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 22, 2014 under the Issuer's 2011 Equity Incentive Plan, as amended. One-third of the RSUs under this grant will vest on each of, (i) February 22, 2016 and (ii) February 22, 2017.
- [F3]The shares of common stock were sold under a pre-planned 10b5-1 trading plan, and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs.
- [F4]On February 24, 2015, the Reporting Person sold an aggregate of 52,330 shares of the Issuer's Common Stock at a weighted average price of $14.63. The highest sale price for the Common Stock was $14.76 per share and the lowest sale price was $14.54 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The RSUs were issued to the Reporting Person on February 23, 2015, pursuant to a grant under the Issuer's 2011 Equity Incentive Plan, as amended. One-third of the RSUs will vest on each of, (i) February 23, 2016, (ii) February 23, 2017 and (iii) February 23, 2018. Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001103021
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 6:02 PM ET
- Size
- 16.5 KB